BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27225590)

  • 1. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
    Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
    Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
    Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
    Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
    Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
    PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.
    Forloni M; Gupta R; Nagarajan A; Sun LS; Dong Y; Pirazzoli V; Toki M; Wurtz A; Melnick MA; Kobayashi S; Homer RJ; Rimm DL; Gettinger SJ; Politi K; Dogra SK; Wajapeyee N
    Cell Rep; 2016 Jul; 16(2):457-471. PubMed ID: 27346347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of
    Misawa K; Mochizuki D; Imai A; Misawa Y; Endo S; Mima M; Kawasaki H; Carey TE; Kanazawa T
    Clin Epigenetics; 2017; 9():64. PubMed ID: 28616099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription.
    Ciccarone F; Valentini E; Bacalini MG; Zampieri M; Calabrese R; Guastafierro T; Mariano G; Reale A; Franceschi C; Caiafa P
    Oncotarget; 2014 Nov; 5(21):10356-67. PubMed ID: 24939750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
    Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
    J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells.
    Fan J; Zhang Y; Mu J; He X; Shao B; Zhou D; Peng W; Tang J; Jiang Y; Ren G; Xiang T
    Clin Epigenetics; 2018 Aug; 10(1):103. PubMed ID: 30075814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl-CpG Binding Domain Protein 2 Inhibits the Malignant Characteristic of Lung Adenocarcinoma through the Epigenetic Modulation of 10 to 11 Translocation 1 and miR-200s.
    Pei YF; Xu XN; Wang ZF; Wang FW; Wu WD; Geng JF; Liu XQ
    Am J Pathol; 2019 May; 189(5):1065-1076. PubMed ID: 30735628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-CpG binding domain protein 1 regulates localization and activity of Tet1 in a CXXC3 domain-dependent manner.
    Zhang P; Rausch C; Hastert FD; Boneva B; Filatova A; Patil SJ; Nuber UA; Gao Y; Zhao X; Cardoso MC
    Nucleic Acids Res; 2017 Jul; 45(12):7118-7136. PubMed ID: 28449087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
    Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
    Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-eleven translocase: key regulator of the methylation landscape in cancer.
    Shekhawat J; Gauba K; Gupta S; Choudhury B; Purohit P; Sharma P; Banerjee M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1869-1879. PubMed ID: 33913031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
    Kudo Y; Tateishi K; Yamamoto K; Yamamoto S; Asaoka Y; Ijichi H; Nagae G; Yoshida H; Aburatani H; Koike K
    Cancer Sci; 2012 Apr; 103(4):670-6. PubMed ID: 22320381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
    Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
    Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.
    Mizuguchi Y; Saiki Y; Horii A; Fukushige S
    Cancer Med; 2016 Sep; 5(9):2522-33. PubMed ID: 27457352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.
    Tricarico R; Madzo J; Scher G; Cohen M; Jelinek J; Maegawa S; Nagarathinam R; Scher C; Chang WC; Nicolas E; Slifker M; Zhou Y; Devarajan K; Cai KQ; Kwok T; Nakajima P; Xu J; Mancuso P; Doneddu V; Bagella L; Williams R; Balachandran S; Maskalenko N; Campbell K; Ma X; Cañadas I; Viana-Errasti J; Moreno V; Valle L; Grivennikov S; Peshkova I; Kurilenko N; Mazitova A; Koltsova E; Lee H; Walsh M; Duttweiler R; Whetstine JR; Yen TJ; Issa JP; Bellacosa A
    Gastroenterology; 2023 May; 164(6):921-936.e1. PubMed ID: 36764492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.